Sato S - Search Results

1

Phase I/II study of combination therapy with S-1 and CPT-11 for metastatic colorectal cancer.

Nakafusa Y, Tanaka M, Ohtsuka T, Miyoshi A, Kohya N, Kitajima Y, Sato S, Mochinaga S, Dohi S, Miyazaki K. Nakafusa Y, et al. Among authors: sato s. Mol Med Rep. 2008 Nov-Dec;1(6):925-30. doi: 10.3892/mmr_00000051. Mol Med Rep. 2008. PMID: 21479507

2

Modification of lymph node dissection for colon cancer by clinical diagnosis.

Nakafusa Y, Tanaka T, Kitajima Y, Sato S, Hirohashi Y, Miyazaki K. Nakafusa Y, et al. Among authors: sato s. Hepatogastroenterology. 2004 May-Jun;51(57):722-6. Hepatogastroenterology. 2004. PMID: 15143901

3

Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome.

Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Nakafusa Y, et al. Among authors: sato s. Dis Colon Rectum. 2004 Dec;47(12):2055-63. doi: 10.1007/s10350-004-0716-7. Dis Colon Rectum. 2004. PMID: 15657654

4

Allelic loss of the DNA repair gene OGG1 against oxidative damage in esophageal squamous cell carcinoma.

Hagiwara A, Kitajima Y, Sato S, Miyazaki K. Hagiwara A, et al. Among authors: sato s. Oncol Rep. 2005 Jun;13(6):1009-16. Oncol Rep. 2005. PMID: 15870915

5

False-positive findings for tumor markers after curative gastrectomy for gastric cancer.

Ohtsuka T, Sato S, Kitajima Y, Tanaka M, Nakafusa Y, Miyazaki K. Ohtsuka T, et al. Among authors: sato s. Dig Dis Sci. 2008 Jan;53(1):73-9. doi: 10.1007/s10620-007-9825-1. Epub 2007 May 3. Dig Dis Sci. 2008. PMID: 17476595

6

Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers.

Ohtsuka T, Nakafusa Y, Sato S, Kitajima Y, Tanaka M, Miyazaki K. Ohtsuka T, et al. Among authors: sato s. Dig Dis Sci. 2008 Jun;53(6):1537-43. doi: 10.1007/s10620-007-0046-4. Dig Dis Sci. 2008. PMID: 17932750

7

Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer.

Kitajima Y, Ohtaka K, Mitsuno M, Tanaka M, Sato S, Nakafusa Y, Miyazaki K. Kitajima Y, et al. Among authors: sato s. Oncol Rep. 2008 Jan;19(1):197-202. Oncol Rep. 2008. PMID: 18097595

8

[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].

Kitajima Y, Yakabe T, Ohtsuka T, Tanaka M, Sato S, Nakafusa Y, Miyazaki K. Kitajima Y, et al. Among authors: sato s. Gan To Kagaku Ryoho. 2009 May;36(5):851-4. Gan To Kagaku Ryoho. 2009. PMID: 19461193 Japanese.

9

Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer.

Yakabe T, Nakafusa Y, Sumi K, Miyoshi A, Kitajima Y, Sato S, Noshiro H, Miyazaki K. Yakabe T, et al. Among authors: sato s. Ann Surg Oncol. 2010 Sep;17(9):2349-56. doi: 10.1245/s10434-010-1004-5. Epub 2010 Mar 9. Ann Surg Oncol. 2010. PMID: 20217258

10

Infectious complications after gastric cancer surgery accelerate a rapid hepatic recurrence.

Ohtsuka T, Kitajima Y, Takahashi T, Sato S, Miyoshi A, Kohya N, Kitahara K, Nakafusa Y, Miyazaki K. Ohtsuka T, et al. Among authors: sato s. Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1277-80. Hepatogastroenterology. 2009. PMID: 19950777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,212 results

Search Page

Filters